Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CDC Lifts Mask Recommendations, Sparking Economic Optimism

U.S. Centers for Disease Control and Prevention guidance says fully vaccinated people can now ditch their masks as a turning point in the U.S. fight against COVID and comes as U.S. caseloads fall and overall vaccinations rise. Tune in below for more insights from Bloomberg’s Ian Fisher. Host: Ian it really does feel like a…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

U.S. Centers for Disease Control and Prevention guidance says fully vaccinated people can now ditch their masks as a turning point in the U.S. fight against COVID and comes as U.S. caseloads fall and overall vaccinations rise. Tune in below for more insights from Bloomberg’s Ian Fisher.

Host: Ian it really does feel like a momentous occasion for the US, where perhaps some semblance of normalcy will return.

Fisher: Yeah, I mean, I think without a doubt, the most significant moment since the first vaccines were rolled out in December, and it took a lot of people by surprise. I mean, there weren’t that many people who were expecting this announcement until some rumblings earlier in the morning. But, you know, while this is in theory, not in theory, it’s being presented as a mask issue, you know, what’s really behind this is vaccines. Two things about them. One is that they work, you know, as you just heard, the CEO just saying, you know, case loads drop, you know, deaths or dropping hospitalizations are dropping quite significantly.

And the second thing is that, you know, there are fewer people are getting them. So there is a lot of pressure on President Biden to start showing some real concrete results to getting vaccinated. So if you can show, you know, some, you know, benefit to getting it, the hope is that more people will get it. And, you know, Biden was very clear about that in his tweet. He basically said, if you’re vaccinated, great, take off your mask if you do not wear it.

Host: Ian talk to me about these COVID zero havens that are actually finding the reopening harder. And what sort of, I guess, warnings or cautionary tale do they present to the rest of the world?

Fisher: Well, it’s hard to tell right now, you know, it’s kind of a case of good news in that, you know, these places, Hong Kong, Singapore, you know, Australia, new Zealand, they’ve done exceptionally well by being exceptionally aggressive in keeping the rest of the world out. So now the rest of the world has kind of come to a point where, you know, vaccines are working. They’re looking at reopening. But at the same time, the rest of the world has learned to accept a greater degree of risk than these places, you know, will accept. Now in the US, 30, 40000, you know, new cases a day. And I think if I think if, you know, these COVID zero places want to rejoin the rest of the world, they’re going to have to accept a larger degree of risk as well.

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

And it really does feel like a momentous occasion for the us, where perhaps some semblance of normalcy will return. Yeah, I mean, I think without a doubt, the most significant moment since the first vaccines were rolled out in December, and it took a lot of people by surprise today. I mean, there weren't that many people who were expecting this announcement until there are some rumblings earlier in the morning. But, you know, while this is in theory, not in theory of it's being presented as a mask issue, you know, what's really behind this is vaccines. Two things about them. One is that they work, you know, as you just heard, the CEO just saying, you know, in case loads drop, you know, deaths or dropping hospitalizations are dropping quite significantly. And the second thing is that, you know, there are fewer people are getting them. So there is a lot of pressure on President Biden to start showing some real concrete results to getting vaccinated. So if you can show, you know, some, you know, benefit to getting it, the hope is that more people will get it. And, you know, Biden was very clear about that in his tweet. basically said, if you're vaccinated, great, take off your mask if you do not wear it. And talk to you about these era havens that have funding, actually the reopening harder. And what sort of, I guess, warnings or cautionary tale. They present to the rest of the world? Well, it's hard to tell right now, you know, kind of a case of good news in that, you know, these places, you know, Hong Kong, Singapore, you know, Australia, new Zealand, they've done exceptionally well by being exceptionally aggressive in keeping the rest of the world out. So now the rest of the world has kind of come to a point where, you know, vaccines are working. You know, they're looking at reopening. But at the same time, the rest of the world has learned to accept a greater degree of risk than these places, you know, will accept. You know, and now in the u.s., 30, 40000, you know, new cases a day. And I think if I think if, you know, these COVID zero places want to rejoin the rest of the world, they're going to have to accept a larger degree of risk as well.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512